| The Effectiveness of Improving Self-care After Counseling for the Diabetics Mellitus Foots Around Chiayi Region (NCT01299246) | Chang Gung Memorial Hospital | 2009-11-01 |
| Purple Grape Juice in Improving Vascular Health in Childhood Cancer Survivors (NCT01043939) | University of Minnesota | 2009-11-01 |
| A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes (NCT01028404) | Novo Nordisk A/S | 2009-11-01 |
| AZD9668 Relative Bioavailability (NCT01035411) | AstraZeneca | 2009-11-01 |
| Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma (NCT00650949) | Gilead Sciences | 2009-11-01 |
| A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma (NCT01015911) | Seagen Inc. | 2009-11-01 |
| In Vitro Human Embryo Culture System (NCT00985218) | Incept BioSystems, Inc. | 2009-11-01 |
| The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia (NCT02274051) | NYU Langone Health | 2009-11-01 |
| Two Inodilators Postsurgery in Neonates (NCT01576094) | Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | 2009-11-01 |
| A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function (NCT00969813) | Pfizer | 2009-11-01 |
| Sorafenib Plus S-1 in Advanced Solid Tumors (NCT01128998) | National Health Research Institutes, Taiwan | 2009-11-01 |
| Allo-Allo Tandem Bone Marrow Transplant (BMT) (NCT00984412) | Hadassah Medical Organization | 2009-11-01 |
| Physical Exercise, Dietary Counseling and Cognitive Behavioral Training as a Combined Intervention to Reduce Weight and Increase Workability in Health Care Workers (NCT01015716) | University of Aarhus | 2009-11-01 |
| Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers (NCT01005797) | Medical University of South Carolina | 2009-11-01 |
| Fractional Photothermolysis for the Treatment of Burn Scars (NCT01005992) | Clinica las Condes, Chile | 2009-11-01 |
| A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours (NCT01065948) | BioTex, Inc. | 2009-11-01 |
| Study to Evaluate the Safety and Immunogenicity of Poly ICLC (Hiltonol) in Healthy Volunteers (NCT01012700) | Rockefeller University | 2009-11-01 |
| CYP2C9 Activity Evaluated With a Simple Finger Prick (NCT01026714) | University Hospital, Geneva | 2009-11-01 |
| Partial Posterior Hyaloidectomy in Macular Surgery (NCT01454466) | Samsung Medical Center | 2009-11-01 |
| HIV Vaccine Study in HIV Positive Patients (NCT01071031) | PepTcell Limited | 2009-11-01 |
| Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel (NCT00989300) | Janssen Cilag S.A.S. | 2009-11-01 |
| An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) (NCT01018238) | Novo Nordisk A/S | 2009-11-01 |
| Caregivers and Electronic Medication Monitoring in Chronic Kidney Disease (NCT01087255) | Harvard Pilgrim Health Care | 2009-11-01 |
| Pulse ACTH vs. MP for MS (NCT01049451) | University of Southern California | 2009-11-01 |
| Reduced Side-Effects of Photodynamic Therapy for the Treatment of Moderate to Severe Acne (i-PDT) (NCT01689935) | Massachusetts General Hospital | 2009-11-01 |
| A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687 (NCT01046357) | AstraZeneca | 2009-11-01 |
| An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer (NCT01514955) | AHS Cancer Control Alberta | 2009-11-01 |
| Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH) (NCT01010425) | Ascendis Pharma A/S | 2009-11-01 |
| Study of Human Central Nervous System (CNS) Stem Cells Transplantation in Pelizaeus-Merzbacher Disease (PMD) Subjects (NCT01005004) | StemCells, Inc. | 2009-11-01 |
| Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers (NCT01014650) | Naurex, Inc, an affiliate of Allergan plc | 2009-11-01 |
| Effect of Rasagiline on BIA 9-1067 Pharmacokinetics (NCT01532141) | Bial - Portela C S.A. | 2009-11-01 |
| A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma (NCT01046266) | Hoffmann-La Roche | 2009-11-01 |
| Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer (NCT01004419) | University of Wisconsin, Madison | 2009-11-01 |
| Study of VX-770 and Rifampin in Healthy Male Subjects (NCT01018368) | Vertex Pharmaceuticals Incorporated | 2009-11-01 |
| Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma (NCT01204450) | UNC Lineberger Comprehensive Cancer Center | 2009-11-01 |
| Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM) (NCT01146262) | Nantes University Hospital | 2009-11-01 |
| Rivastigmine Study in Adolescents With Down Syndrome (NCT01084135) | Duke University | 2009-11-01 |
| Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic (NCT01519284) | Bial - Portela C S.A. | 2009-11-01 |
| Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer (NCT01003808) | ImmunoFrontier, Inc. | 2009-11-01 |
| TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer (NCT01108042) | Orlando Guntinas-Lichius, Prof. Dr. med. | 2009-11-01 |
| Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release (NCT00988949) | Pfizer | 2009-11-01 |
| A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers (NCT00999817) | Pfizer | 2009-11-01 |
| Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD) (NCT00993291) | Vanderbilt University | 2009-11-01 |
| A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer (NCT01023386) | Astellas Pharma Inc | 2009-11-01 |
| An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease (NCT01013610) | Link Medicine Corporation | 2009-11-01 |
| Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately (NCT01015729) | AstraZeneca | 2009-11-01 |
| Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload (NCT01039636) | FerroKin BioSciences, Inc. | 2009-11-01 |
| Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects (NCT01012310) | Pfizer | 2009-11-01 |
| Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers (NCT01028924) | Nycomed | 2009-11-01 |
| Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer (NCT00916877) | Alberta Health services | 2009-11-01 |
| A Study of the Safety and Effectiveness of Two New Malaria Vaccines (NCT01003314) | University of Oxford | 2009-11-01 |
| Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies (NCT01015222) | M.D. Anderson Cancer Center | 2009-11-01 |
| An Investigation of the Absorption and Pharmacokinetics of Multiple Doses of Three Controlled Release Pregabalin Tablets as Compared to Multiple Doses of the Immediate Release Pregabalin Capsule (NCT01009541) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-11-01 |
| Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia (NCT01032317) | Biosense Webster, Inc. | 2009-11-01 |
| Feasibility of Comparing Two Surgical Treatment of Female Urodynamic Stress (NCT01230450) | University of Aberdeen | 2009-11-01 |
| Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia (NCT01019681) | Richard Burt, MD | 2009-11-01 |
| A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc. (NCT01039610) | GlaxoSmithKline | 2009-11-01 |
| Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies (NCT01061749) | National Cancer Institute (NCI) | 2009-11-01 |
| Hydroxychloroquine + Vorinostat in Advanced Solid Tumors (NCT01023737) | The University of Texas Health Science Center at San Antonio | 2009-11-01 |
| A Dosing and Efficacy Study of Intra-nasal Sufentanil for Moderate to Severe Pain (NCT01012999) | University of Utah | 2009-11-01 |
| Use of Tendon Vibration and Mirror for the Improvement of Upper Limb Function and Pain Reduction (NCT01010607) | Hadassah Medical Organization | 2009-11-01 |
| Performance Study Using the OptiScanner on Healthy Diabetics (NCT01135771) | Profil Institut für Stoffwechselforschung GmbH | 2009-11-01 |
| ENGAGE - Meeting Mental Health Needs of Complex Comorbid Patients (NCT00980824) | University of Glasgow | 2009-11-01 |
| South American Abdominal Stent Graft Trial (NCT01082185) | TriVascular, Inc. | 2009-11-01 |
| Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases (NCT01018836) | Rutgers, The State University of New Jersey | 2009-11-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults (NCT01042106) | Sumitomo Pharma America, Inc. | 2009-11-01 |
| Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP) (NCT01020747) | Massachusetts General Hospital | 2009-11-01 |
| Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial (NCT01011335) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2009-11-01 |
| This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses (NCT01027234) | AstraZeneca | 2009-11-01 |
| A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects (NCT00991159) | Pfizer | 2009-11-01 |
| RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia (NCT00968253) | M.D. Anderson Cancer Center | 2009-11-01 |
| A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function (NCT01006057) | Novo Nordisk A/S | 2009-11-01 |
| Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) (NCT00935987) | Sierra Oncology LLC - a GSK company | 2009-11-01 |
| Percutaneous Renal Tumor Cryoablation Followed by Biopsy (NCT01012427) | Memorial Sloan Kettering Cancer Center | 2009-11-01 |
| Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor (NCT01001221) | Sanofi | 2009-11-01 |
| Physical Activity in Patients With Systemic Lupus Erythematosus (NCT00985803) | Federal University of São Paulo | 2009-11-01 |
| A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) (NCT01012219) | Merck Sharp & Dohme LLC | 2009-11-01 |
| Lenalidomide and Paclitaxel in Advanced Solid Tumors (NCT01155505) | Southern Europe New Drug Organization | 2009-11-01 |
| A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers (NCT00990756) | Pfizer | 2009-11-01 |
| Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions (NCT01003106) | Peter A Campochiaro, MD | 2009-11-01 |
| Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients (NCT01232010) | Asan Medical Center | 2009-11-01 |
| Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328) (NCT01345786) | Organon and Co | 2009-11-01 |
| Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers. (NCT02183662) | Boehringer Ingelheim | 2009-11-01 |
| Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01013142) | MediciNova | 2009-11-01 |
| Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia (NCT01034592) | Jason Robert Gotlib | 2009-11-01 |
| Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity (NCT00953849) | VA Office of Research and Development | 2009-11-01 |
| Interventions of Smoking Cessation During Pregnancy (NCT01210118) | Hellenic Anticancer Society | 2009-11-01 |
| Apremilast in the Treatment of Uveitis (NCT00889421) | Oregon Health and Science University | 2009-11-01 |
| Figitumumab Combined With Pegvisomant For Advanced Solid Tumors (NCT00976508) | Pfizer | 2009-11-01 |
| An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML) (NCT01019161) | AstraZeneca | 2009-11-01 |
| Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B) (NCT02220673) | Boehringer Ingelheim | 2009-11-01 |
| Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) (NCT01016769) | Memorial Sloan Kettering Cancer Center | 2009-11-01 |
| A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers (NCT01002625) | Pfizer | 2009-11-01 |
| In Vivo Confocal Microscopy Tumor Atlas Study (NCT01012154) | Carl Zeiss Surgical GmbH | 2009-11-01 |
| A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects (NCT01013064) | Hanmi Pharmaceutical Company Limited | 2009-11-01 |
| Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks (NCT00969397) | University of California, Irvine | 2009-11-01 |
| Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia (NCT01049113) | Traws Pharma, Inc. | 2009-11-01 |
| AeriSeal System for Lung Volume Reduction (NCT01051258) | Aeris Therapeutics | 2009-11-01 |
| Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers (NCT00981695) | Medical Research Council | 2009-11-01 |
| Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis (NCT01007175) | Ablynx, a Sanofi company | 2009-11-01 |